Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma
Conditions
- Gastroesophageal Adenocarcinoma
Interventions
- DRUG: Paclitaxel
- DRUG: Ramucirumab
- DRUG: Zanidatamab
Sponsor
Canadian Cancer Trials Group
Collaborators